|
WO2002008288A2
(en)
*
|
2000-07-20 |
2002-01-31 |
Genentech, Inc. |
Secreted and transmembrane polypeptides and nucleic acids encoding the same
|
|
WO1999060127A2
(en)
|
1998-05-15 |
1999-11-25 |
Genentech, Inc. |
Il-17 homologous polypeptides and therapeutic uses thereof
|
|
US20020137890A1
(en)
|
1997-03-31 |
2002-09-26 |
Genentech, Inc. |
Secreted and transmembrane polypeptides and nucleic acids encoding the same
|
|
US7579160B2
(en)
|
1998-03-18 |
2009-08-25 |
Corixa Corporation |
Methods for the detection of cervical cancer
|
|
US6960570B2
(en)
|
1998-03-18 |
2005-11-01 |
Corixa Corporation |
Compositions and methods for the therapy and diagnosis of lung cancer
|
|
US6706262B1
(en)
|
1998-03-18 |
2004-03-16 |
Corixa Corporation |
Compounds and methods for therapy and diagnosis of lung cancer
|
|
US7258860B2
(en)
|
1998-03-18 |
2007-08-21 |
Corixa Corporation |
Compositions and methods for the therapy and diagnosis of lung cancer
|
|
US7771719B1
(en)
|
2000-01-11 |
2010-08-10 |
Genentech, Inc. |
Pharmaceutical compositions, kits, and therapeutic uses of antagonist antibodies to IL-17E
|
|
US6929938B2
(en)
|
2001-08-15 |
2005-08-16 |
Millennium Pharmaceuticals, Inc. |
25501, a human transferase family member and uses therefor
|
|
US7141417B1
(en)
|
1999-02-25 |
2006-11-28 |
Thomas Jefferson University |
Compositions, kits, and methods relating to the human FEZ1 gene, a novel tumor suppressor gene
|
|
JP2003508011A
(en)
*
|
1999-02-25 |
2003-03-04 |
トマス・ジエフアーソン・ユニバーシテイ |
Compositions, kits and methods relating to a novel tumor suppressor gene that is the human FEZ1 gene
|
|
EP1157038A4
(en)
*
|
1999-02-26 |
2005-01-19 |
Smithkline Beecham Corp |
Cloning of a p2y-like 7tm receptor (axor17)
|
|
AU3885400A
(en)
*
|
1999-03-23 |
2000-10-09 |
Human Genome Sciences, Inc. |
48 human secreted proteins
|
|
WO2000058480A1
(en)
|
1999-03-29 |
2000-10-05 |
Kansai Technology Licensing Organization Co., Ltd. |
Novel cytidine deaminase
|
|
US6602501B1
(en)
|
1999-08-12 |
2003-08-05 |
Agensys, Inc. |
C-type lectin transmembrane antigen expressed in human prostate cancer and uses thereof
|
|
EP1621620A3
(en)
*
|
1999-09-01 |
2006-05-10 |
Genetech, Inc. |
Secreted and transmembrane polypeptides and nucleic acids encoding the same
|
|
US20020151047A1
(en)
*
|
2001-01-08 |
2002-10-17 |
Yi Hu |
Novel human protease and polynucleotides encoding the same
|
|
US6617147B2
(en)
|
2000-04-25 |
2003-09-09 |
Lexicon Genetics Incorporated |
Human kinase proteins and polynucleotides encoding the same
|
|
AU1238201A
(en)
*
|
1999-10-27 |
2001-05-08 |
Millennium Pharmaceuticals, Inc. |
Novel molecules and the card-related protein family and uses thereof
|
|
US6893818B1
(en)
|
1999-10-28 |
2005-05-17 |
Agensys, Inc. |
Gene upregulated in cancers of the prostate
|
|
US7005499B1
(en)
*
|
1999-11-18 |
2006-02-28 |
Genentech, Inc. |
Wnt-regulated cytokine-like polypeptide and nucleic acids encoding same
|
|
EP1878794A3
(en)
*
|
1999-11-30 |
2008-01-23 |
Genentech, Inc. |
Compositions and methods for the treatment of immune related diseases
|
|
EP1666495A1
(en)
*
|
1999-12-01 |
2006-06-07 |
Genentech, Inc. |
Secreted and transmembrane polypeptides and nucleic acids encoding the same
|
|
CN1300781A
(en)
*
|
1999-12-22 |
2001-06-27 |
上海博德基因开发有限公司 |
Polypeptide-human SHC protein 43 and polynucleotide for coding this polypeptide
|
|
US20040043397A1
(en)
|
2000-01-11 |
2004-03-04 |
Genentech, Inc. |
IL-17 homologous polypeptides and therapeutic uses thereof
|
|
EP1250434B1
(en)
|
2000-01-26 |
2008-04-16 |
Agensys, Inc. |
84p2a9: a prostate and testis specific protein highly expressed in prostate cancer
|
|
US6953682B2
(en)
|
2000-02-10 |
2005-10-11 |
Millennium Pharmaceuticals, Inc. |
Nucleic acid sequences encoding adenylate kinase, phospholipid scramblase-like, DNA fragmentation factor-like, phosphatidylserine synthase-like, and atpase-like molecules and uses therefor
|
|
US20020082212A1
(en)
*
|
2000-07-20 |
2002-06-27 |
Millennium Pharmaceuticals, Inc. |
7716, a novel human ATPase and uses therefor
|
|
US7078205B2
(en)
|
2000-02-17 |
2006-07-18 |
Millennium Pharmaceuticals, Inc. |
Nucleic acid sequences encoding melanoma associated antigen molecules, aminotransferase molecules, atpase molecules, acyltransferase molecules, pyridoxal-phosphate dependent enzyme molecules and uses therefor
|
|
US20020090705A1
(en)
*
|
2000-07-14 |
2002-07-11 |
Rachel Meyers |
62088, a novel human nucleoside phosphatase family member and uses thereof
|
|
US20020055159A1
(en)
*
|
2000-06-15 |
2002-05-09 |
Meyers Rachel A. |
23680,a novel human aminotransferase and uses therefor
|
|
US7718397B2
(en)
|
2000-03-21 |
2010-05-18 |
Genentech, Inc. |
Nucleic acids encoding receptor for IL-17 homologous polypeptides and uses thereof
|
|
JP2003527860A
(en)
*
|
2000-03-23 |
2003-09-24 |
イミューソル インコーポレイテッド |
BRCA-1 regulatory factors and methods of use
|
|
EP1272640A2
(en)
|
2000-03-24 |
2003-01-08 |
Millennium Pharmaceuticals, Inc. |
3714, 16742, 23546, and 13887 novel protein kinase molecules and uses therefor
|
|
US20030198953A1
(en)
*
|
2000-03-30 |
2003-10-23 |
Spytek Kimberly A. |
Novel proteins and nucleic acids encoding same
|
|
US7632929B2
(en)
|
2000-04-20 |
2009-12-15 |
The Board Of Trustees Of The University Of Arkansas |
Methamphetamine-like hapten compounds, linkers, carriers and compositions and uses thereof
|
|
EP1280917A2
(en)
*
|
2000-04-26 |
2003-02-05 |
Millennium Pharmaceuticals, Inc. |
21657, a human short-chain dehydrogenase and uses thereof
|
|
US6808876B1
(en)
*
|
2000-05-02 |
2004-10-26 |
Immusol, Inc. |
Cellular regulators of infectious agents and methods of use
|
|
JP2003532412A
(en)
*
|
2000-05-12 |
2003-11-05 |
メルク パテント ゲゼルシャフト ミット ベシュレンクテル ハフトング |
Novel serine-threonine kinase-4
|
|
EP1158001B1
(en)
*
|
2000-05-26 |
2007-11-14 |
F. Hoffmann-La Roche Ag |
A nucleic acid which is upregulated in human tumor cells, a protein encoded thereby and a process for tumor diagnosis
|
|
AU7634301A
(en)
*
|
2000-05-26 |
2001-12-03 |
Bayer Aktiengesellschaft |
Regulation of human p78-like serine/threonine kinase
|
|
DE10027170A1
(en)
*
|
2000-05-31 |
2001-12-13 |
Schering Ag |
Human PEM as a target for fertility control
|
|
AU6531101A
(en)
*
|
2000-06-02 |
2001-12-17 |
Genentech Inc |
Secreted and transmembrane polypeptides and nucleic acids encoding the same
|
|
US7098311B2
(en)
*
|
2000-06-02 |
2006-08-29 |
Brigham And Women's Hospital |
Fusion of jAZF1 and jjAZ1 genes in endometrial stromal tumors
|
|
US20030096969A1
(en)
|
2000-06-02 |
2003-05-22 |
Genentech, Inc. |
Secreted and transmembrane polypeptides and nucleic acids encoding the same
|
|
WO2001094385A2
(en)
*
|
2000-06-05 |
2001-12-13 |
Bayer Aktiengesellschaft |
Human hm74-like g protein coupled receptor
|
|
WO2001096390A2
(en)
*
|
2000-06-09 |
2001-12-20 |
Corixa Corporation |
Compositions and methods for the therapy and diagnosis of colon cancer
|
|
US6323016B1
(en)
|
2000-06-09 |
2001-11-27 |
Pe Corporation (Ny) |
Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof
|
|
JP2004513620A
(en)
*
|
2000-06-16 |
2004-05-13 |
インサイト・ゲノミックス・インコーポレイテッド |
Protein phosphatase
|
|
EP2077276A1
(en)
*
|
2000-06-23 |
2009-07-08 |
Genentech, Inc. |
Compositions and methods for the diagnosis and treatment of disorders involving angiogensis
|
|
EP1325114A2
(en)
*
|
2000-06-26 |
2003-07-09 |
Millennium Pharmaceuticals, Inc. |
A human beta-ketoacyl synthase (46619) and uses thereof
|
|
JP2004501623A
(en)
*
|
2000-06-27 |
2004-01-22 |
キュラジェン コーポレイション |
Polynucleotides and polypeptides encoded thereby
|
|
US7094587B2
(en)
|
2000-06-27 |
2006-08-22 |
Millennium Pharmaceuticals, Inc. |
16002 Molecules and uses therefor
|
|
US6774223B2
(en)
|
2000-06-28 |
2004-08-10 |
Diadexus, Inc. |
Method of diagnosing, monitoring, staging, imaging and treating colon cancer
|
|
WO2002002761A2
(en)
*
|
2000-06-30 |
2002-01-10 |
Millennium Pharmaceuticals, Inc. |
57658, a human uridine kinase and uses thereof
|
|
WO2002004510A2
(en)
*
|
2000-07-07 |
2002-01-17 |
Incyte Genomics, Inc. |
Gtp-binding proteins
|
|
CA2415808A1
(en)
*
|
2000-07-07 |
2002-01-17 |
Incyte Genomics, Inc. |
Transporters and ion channels
|
|
US6740751B2
(en)
|
2000-07-18 |
2004-05-25 |
Board Of Regents, The University Of Texas System |
Methods and compositions for stabilizing microtubules and intermediate filaments in striated muscle cells
|
|
WO2002006453A2
(en)
*
|
2000-07-18 |
2002-01-24 |
Bayer Aktiengesellschaft |
Regulation of human desc1-like serine protease
|
|
US20060252034A1
(en)
*
|
2000-07-25 |
2006-11-09 |
Klaus Duecker |
Novel protein containing ring finger domaine r1p4
|
|
WO2002008281A2
(en)
*
|
2000-07-26 |
2002-01-31 |
Stanford University |
Bstp-cad protein and related reagents and methods of use thereof
|
|
AU2001277202A1
(en)
*
|
2000-07-26 |
2002-02-05 |
Applied Genomics, Inc. |
Bstp-ras/rerg protein and related reagents and methods of use thereof
|
|
EP1657254A3
(en)
*
|
2000-08-01 |
2006-06-07 |
Genentech, Inc. |
Polypeptide, nucleic acid encoding it, and their use for the diagnosis of cancer
|
|
US7335732B2
(en)
|
2000-08-01 |
2008-02-26 |
Genentech, Inc. |
PRO9799 polypeptides
|
|
US20020187138A1
(en)
*
|
2000-08-02 |
2002-12-12 |
Rachel Meyers |
15368, a novel human GTP-releasing factor family member and uses therefor
|
|
CA2416732C
(en)
|
2000-08-02 |
2016-02-09 |
Brad St. Croix |
Endothelial cell expression patterns
|
|
US6924364B2
(en)
|
2000-08-04 |
2005-08-02 |
Zymogenetics, Inc. |
Human secreted protein, Zzp1
|
|
US6943245B2
(en)
|
2000-08-10 |
2005-09-13 |
Board Of Regents, The University Of Texas System |
Tumor suppressor CAR-1
|
|
JP2004506422A
(en)
*
|
2000-08-11 |
2004-03-04 |
メルク パテント ゲゼルシャフト ミット ベシュレンクテル ハフトング |
Novel mitogen-activated kinase
|
|
EP1326985A1
(en)
*
|
2000-08-18 |
2003-07-16 |
MERCK PATENT GmbH |
Identification of a human n-terminal acetyltransferase gene
|
|
US6706513B2
(en)
|
2000-08-21 |
2004-03-16 |
Bristol-Myers Squibb Company |
Adenosine deaminase homolog
|
|
US6962799B2
(en)
*
|
2000-08-21 |
2005-11-08 |
Incyte Corporation |
Microtubule-associated proteins and tubulins
|
|
AU2001284655A1
(en)
*
|
2000-08-24 |
2002-03-04 |
Eli Lilly And Company |
Nucleic acids, vectors, host cells, polypeptides and uses thereof
|
|
EP1334189A2
(en)
*
|
2000-08-28 |
2003-08-13 |
AstraZeneca AB |
Molecules involved in the regulation of insulin resistance syndrome (irs)
|
|
EP1313761A4
(en)
*
|
2000-08-28 |
2005-01-26 |
Human Genome Sciences Inc |
18 human secreted proteins
|
|
EP2022797A3
(en)
|
2000-08-28 |
2011-11-09 |
Agensys, Inc. |
Nucleic acid and corresponding protein entitled 85P1B3 useful in treatment and detection of cancer
|
|
AU2001286815A1
(en)
*
|
2000-08-30 |
2002-03-13 |
Millennium Pharmaceuticals, Inc. |
48921, a novel human gtp releasing factor and uses therefor
|
|
AU2001285908A1
(en)
*
|
2000-08-30 |
2002-03-13 |
Bayer Aktiengesellschaft |
Regulation of human aminotransferase-like enzyme
|
|
AU2002210464A1
(en)
*
|
2000-08-30 |
2002-03-13 |
Bayer Aktiengesellschaft |
Regulation of human aminotransferase-like enzyme
|
|
AU2001286714A1
(en)
*
|
2000-08-30 |
2002-03-13 |
Millennium Pharmaceuticals, Inc. |
54370, a novel human sulfate transporter and uses therefor
|
|
US7166428B2
(en)
|
2000-08-31 |
2007-01-23 |
Millennium Pharmaceuticals, Inc. |
62112, a novel human dehydrogenase and uses thereof
|
|
EP1364015A2
(en)
*
|
2000-09-05 |
2003-11-26 |
Incyte Genomics, Inc. |
Molecules for diagnostics and therapeutics
|
|
ES2327102T3
(en)
*
|
2000-09-05 |
2009-10-26 |
Amgen Inc. |
MOLECULES ANALOG TO THE RECEIVER OF TNF AND USES OF THE SAME.
|
|
WO2002020765A2
(en)
*
|
2000-09-08 |
2002-03-14 |
Millennium Pharmaceuticals, Inc. |
38646, a guanine nucleotide exchange factor and uses therefor
|
|
US6372468B1
(en)
*
|
2000-09-14 |
2002-04-16 |
Pe Corporation (Ny) |
Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof
|
|
US6391606B1
(en)
*
|
2000-09-14 |
2002-05-21 |
Pe Corporation |
Isolated human phospholipase proteins, nucleic acid molecules encoding human phospholipase proteins, and uses thereof
|
|
US20040010119A1
(en)
*
|
2001-02-12 |
2004-01-15 |
Xiaojia Guo |
Novel proteins and nucleic acids encoding same
|
|
CA2424199A1
(en)
*
|
2000-10-05 |
2002-04-11 |
Curagen Corporation |
Novel human proteins, polynucleotides encoding them and methods of using the same
|
|
WO2002031126A2
(en)
*
|
2000-10-11 |
2002-04-18 |
Bayer Aktiengesellschaft |
Regulation of human cyclophilin-type peptidyl-prolyl cis-trans isomerase
|
|
EP1402010A2
(en)
*
|
2000-10-11 |
2004-03-31 |
Millennium Pharmaceuticals, Inc. |
8843, a human dual specificity phosphatase family member and uses therefor
|
|
WO2002031143A2
(en)
*
|
2000-10-12 |
2002-04-18 |
The Texas A & M University System |
Nucleic acid sequences encoding cmg proteins cmg proteins and methods for their use
|
|
AU2002215345A1
(en)
*
|
2000-10-13 |
2002-04-22 |
Eos Biotechnology, Inc. |
Methods of diagnosis of prostate cancer, compositions and methods of screening for modulators of prostate cancer
|
|
US6531297B2
(en)
*
|
2000-10-20 |
2003-03-11 |
Applera Corporation |
Isolated human drug-metabolizing proteins, nucleic acid molecules encoding human drug-metabolizing proteins, and uses thereof
|
|
US6846650B2
(en)
|
2000-10-25 |
2005-01-25 |
Diadexus, Inc. |
Compositions and methods relating to lung specific genes and proteins
|
|
AU2002220668A1
(en)
*
|
2000-10-31 |
2002-05-15 |
Bayer Aktiengesellschaft |
Regulation of human glutathione-s-transferase
|
|
AU2002229011A1
(en)
*
|
2000-11-09 |
2002-05-21 |
Glaxo Group Limited |
Deaminase catalyzing the removal of the cyclopropyl moiety from abacavir-mp
|
|
US6855517B2
(en)
|
2000-11-20 |
2005-02-15 |
Diadexus, Inc. |
Compositions and methods relating to breast specific genes and proteins
|
|
WO2002081667A2
(en)
*
|
2000-12-05 |
2002-10-17 |
Incyte Genomics, Inc. |
Ligases
|
|
EP1339845A2
(en)
|
2000-12-07 |
2003-09-03 |
ZymoGenetics, Inc. |
Adipocyte complemented related protein zacrp3x2
|
|
JP2004535765A
(en)
|
2000-12-07 |
2004-12-02 |
カイロン コーポレイション |
Endogenous retrovirus up-regulated in prostate cancer
|
|
AU2002211305A1
(en)
*
|
2000-12-14 |
2002-06-24 |
Pe Corporation (Ny) |
Isolated human kinase proteins, their encoding nucleic acid molecules, and uses thereof
|
|
US20020142376A1
(en)
*
|
2000-12-20 |
2002-10-03 |
Gennady Merkulov |
Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof
|
|
ATE329027T1
(en)
|
2000-12-22 |
2006-06-15 |
Brystol Myers Squibb Company |
HUMAN LEUCINE-RICH REPEATS CONTAINING PROTEIN EXPRESSED PRIMARY IN THE SMALL INTESTINE, HLRRSI1
|
|
US7892730B2
(en)
*
|
2000-12-22 |
2011-02-22 |
Sagres Discovery, Inc. |
Compositions and methods for cancer
|
|
US6423521B1
(en)
|
2000-12-28 |
2002-07-23 |
Pe Corporation (Ny) |
Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof
|
|
WO2002053591A1
(en)
*
|
2000-12-30 |
2002-07-11 |
Lion Bioscience Ag |
Mammalian nuclear receptor cofactor cf12 and methods of use
|
|
US20030219739A1
(en)
*
|
2001-01-30 |
2003-11-27 |
Glass David J. |
Novel nucleic acid and polypeptide molecules
|
|
EP1637601A3
(en)
*
|
2001-02-21 |
2006-03-29 |
Curagen Corporation |
Proteins, polynucleotides encoding them and methods of using the same
|
|
WO2002072786A2
(en)
|
2001-03-13 |
2002-09-19 |
Corvas International, Inc. |
Nucleic acid molecules encoding a transmembrane serine protease 7, the encoded polypeptides and methods based thereon
|
|
US7271240B2
(en)
|
2001-03-14 |
2007-09-18 |
Agensys, Inc. |
125P5C8: a tissue specific protein highly expressed in various cancers
|
|
AU2002250143A1
(en)
*
|
2001-03-16 |
2002-10-03 |
Eli Lilly And Company |
Lp mammalian proteins; related reagents
|
|
US7172892B2
(en)
|
2001-03-22 |
2007-02-06 |
Dendreon Corporation |
Nucleic acid molecules encoding serine protease CVSP14, the encoded polypeptides and methods based thereon
|
|
WO2002077267A2
(en)
|
2001-03-27 |
2002-10-03 |
Dendreon San Diego Llc |
Nucleic acid molecules encoding a transmembran serine protease 9, the encoded polypeptides and methods based thereon
|
|
US6913904B2
(en)
*
|
2001-03-27 |
2005-07-05 |
Applera Corporation |
Isolated human Ras-like proteins, nucleic acid molecules encoding these human Ras-like proteins, and uses thereof
|
|
US7033790B2
(en)
|
2001-04-03 |
2006-04-25 |
Curagen Corporation |
Proteins and nucleic acids encoding same
|
|
AU2002318112B2
(en)
|
2001-04-10 |
2007-12-06 |
Agensys, Inc. |
Nucleic acids and corresponding proteins useful in the detection and treatment of various cancers
|
|
AU2002258626B2
(en)
|
2001-04-10 |
2007-01-18 |
Agensys, Inc. |
Nucleid acid and corresponding protein entitled 158P3D2 useful in treatment and detection of cancer
|
|
PT1573022E
(en)
|
2001-04-10 |
2011-08-23 |
Agensys Inc |
Nucleic acid and corresponding protein entitled 184p1e2 useful in treatment and detection of cancer
|
|
JPWO2002088175A1
(en)
*
|
2001-04-24 |
2004-08-19 |
大塚製薬株式会社 |
Antibody binding peptide for Crohn's disease and method for testing Crohn's disease
|
|
AU2002249453A1
(en)
*
|
2001-04-24 |
2002-11-05 |
Isis Innovation Ltd |
Enzyme and snp marker for disease
|
|
US20050158719A1
(en)
*
|
2001-05-07 |
2005-07-21 |
Yasufumi Sato |
Polypeptide serving as angiogenic marker and dna thereof
|
|
AU2002314048A1
(en)
*
|
2001-05-09 |
2002-11-18 |
Bayer Aktiengesellschaft |
Regulation of human phosphatidic acid phosphatase type 2c-like protein
|
|
US7112430B2
(en)
|
2001-05-14 |
2006-09-26 |
Dendreon Corporation |
Nucleic acid molecules encoding a transmembrane serine protease 10, the encoded polypeptides and methods based thereon
|
|
US7157558B2
(en)
|
2001-06-01 |
2007-01-02 |
Genentech, Inc. |
Polypeptide encoded by a polynucleotide overexpresses in tumors
|
|
US7026121B1
(en)
|
2001-06-08 |
2006-04-11 |
Expression Diagnostics, Inc. |
Methods and compositions for diagnosing and monitoring transplant rejection
|
|
US6905827B2
(en)
|
2001-06-08 |
2005-06-14 |
Expression Diagnostics, Inc. |
Methods and compositions for diagnosing or monitoring auto immune and chronic inflammatory diseases
|
|
US7235358B2
(en)
|
2001-06-08 |
2007-06-26 |
Expression Diagnostics, Inc. |
Methods and compositions for diagnosing and monitoring transplant rejection
|
|
AU2002311535A1
(en)
*
|
2001-06-26 |
2003-01-08 |
Decode Genetics Ehf. |
Nucleic acids encoding protein kinases
|
|
GB2399086A
(en)
*
|
2001-08-02 |
2004-09-08 |
Aeomica Inc |
Human zinc finger containing gene MDZ4
|
|
AU2002359242A1
(en)
*
|
2001-08-17 |
2003-04-22 |
Incyte Genomics, Inc. |
Intracellular signaling molecules
|
|
US7270960B2
(en)
*
|
2001-08-29 |
2007-09-18 |
Pacific Northwest Research Institute |
Diagnosis of ovarian carcinomas
|
|
WO2003023063A1
(en)
*
|
2001-09-07 |
2003-03-20 |
Sankyo Company, Limited |
Method of judging onset risk of diabetes
|
|
WO2003025175A2
(en)
*
|
2001-09-17 |
2003-03-27 |
Molecular Engines Laboratories |
Sequences involved in phenomena of tumour suppression, tumour reversion, apoptosis and/or virus resistance and their use as medicines
|
|
WO2003040369A2
(en)
*
|
2001-09-17 |
2003-05-15 |
Molecular Engines Laboratories |
Sequences involved in tumoral suppression, tumoral reversion, apoptosis and/or viral resistance phenomena and their use as medicines
|
|
JP2005534279A
(en)
|
2001-09-28 |
2005-11-17 |
ブリガム ヤング ユニバーシティ |
Novel cyclooxygenase variants and methods of use
|
|
JPWO2003038087A1
(en)
|
2001-10-04 |
2005-02-24 |
関西ティー・エル・オー株式会社 |
Promoter of DR5 gene and promoter of Siah-1 gene
|
|
US7084257B2
(en)
|
2001-10-05 |
2006-08-01 |
Amgen Inc. |
Fully human antibody Fab fragments with human interferon-gamma neutralizing activity
|
|
WO2003031607A1
(en)
*
|
2001-10-10 |
2003-04-17 |
Bayer Healthcare Ag |
Regulation of human short-chain dehydrogenase/reductase
|
|
DE60220621T2
(en)
|
2001-11-09 |
2008-03-06 |
Proteologics, Inc. |
Posh nucleic acid, polypeptides and related methods
|
|
WO2003054146A2
(en)
|
2001-11-14 |
2003-07-03 |
Northwestern University |
Self-assembly and mineralization of peptide-amphiphile nanofibers
|
|
US20050053940A1
(en)
*
|
2001-11-21 |
2005-03-10 |
Joh-E Ikeda |
Huntington's disease gene transcriptional factors
|
|
US7151162B2
(en)
|
2001-12-06 |
2006-12-19 |
The University Of Children's Hospital Of Both Cantons Of Basel |
Nuclear protein
|
|
WO2003051911A2
(en)
*
|
2001-12-19 |
2003-06-26 |
Genset S.A. |
Gmg-5 polynucleotides and polypeptides and uses thereof
|
|
JP2003245084A
(en)
|
2001-12-20 |
2003-09-02 |
Morinaga Milk Ind Co Ltd |
Novel gene useful for diagnosis and treatment of corpus callosum or sperm dysplasia, and use thereof
|
|
DE10163467A1
(en)
*
|
2001-12-21 |
2003-11-27 |
Axaron Bioscience Ag |
New DNA sequence encoding protein 24B2, useful for treatment and diagnosis or cancer and degenerative diseases, also related polypeptides and modulators
|
|
US6759222B2
(en)
|
2002-01-02 |
2004-07-06 |
Millennium Pharmaceuticals, Inc. |
14815, a human kinase family member and uses therefor
|
|
AU2003202543A1
(en)
*
|
2002-01-07 |
2003-07-24 |
Bayer Aktiengesellschaft |
Human phosphatidic acid phosphatase type 2-like protein
|
|
WO2003060109A2
(en)
*
|
2002-01-15 |
2003-07-24 |
Bayer Healthcare Ag |
Human subtilisin/kexin-like convertase
|
|
AU2003205611A1
(en)
*
|
2002-01-15 |
2003-07-30 |
Medigene Ag |
Dilated cardiomyopathy associated gene-2 (dcmag-2): a cytoplasmatic inducer of sarcomeric remodeling in cardiomyocytes
|
|
JPWO2003062429A1
(en)
*
|
2002-01-23 |
2005-05-26 |
山之内製薬株式会社 |
New serine protease
|
|
AU2003215280A1
(en)
|
2002-02-15 |
2003-09-09 |
Northwestern University |
Self-assembly of peptide-amphiphile nanofibers under physiological conditions
|
|
EP1338609A1
(en)
*
|
2002-02-21 |
2003-08-27 |
MEMOREC Stoffel GmbH-Medizinisch-Molekulare Entwicklung, Köln |
A further KDR receptor and the use thereof
|
|
WO2003076645A2
(en)
*
|
2002-03-05 |
2003-09-18 |
Applera Corporation |
Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof
|
|
WO2003074557A1
(en)
*
|
2002-03-06 |
2003-09-12 |
Oxford Glycosciences (Uk) Ltd |
Novel b-cell malignancy-associated protein
|
|
EP2261368A1
(en)
|
2002-03-13 |
2010-12-15 |
Genomic Health, Inc. |
Gene expression profiling in biopsied tumor tissues
|
|
AU2003220913A1
(en)
*
|
2002-03-19 |
2003-09-29 |
Tanabe Seiyaku Co., Ltd. |
Novel g protein-coupled recepotrs and genes thereof
|
|
US7527935B2
(en)
|
2002-03-19 |
2009-05-05 |
Mitsubishi Tanabe Pharma Corporation |
G-protein coupled receptor having eicosanoid as ligand and gene thereof
|
|
GB0206684D0
(en)
*
|
2002-03-21 |
2002-05-01 |
Babraham Inst |
Novel proteins
|
|
US7193069B2
(en)
|
2002-03-22 |
2007-03-20 |
Research Association For Biotechnology |
Full-length cDNA
|
|
CA2413475C
(en)
|
2002-04-25 |
2010-07-27 |
The Government Of The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services |
Zap-70 expression as a marker for chronic lymphocytic leukemia/small lymphocytic lymphoma (cll/sll)
|
|
JP2004041003A
(en)
*
|
2002-05-17 |
2004-02-12 |
Takeda Chem Ind Ltd |
New protein, its dna and use thereof
|
|
EP1507553A2
(en)
|
2002-05-29 |
2005-02-23 |
DeveloGen Aktiengesellschaft für entwicklungsbiologische Forschung |
Pancreas-specific proteins
|
|
AU2003237367A1
(en)
|
2002-06-03 |
2003-12-19 |
Chiron Corporation |
Use of nrg4, or inhibitors thereof, in the treatment of colon and pancreatic cancer
|
|
ATE500326T1
(en)
|
2002-06-06 |
2011-03-15 |
Oncotherapy Science Inc |
GENES AND PROTEINS RELATED TO HUMAN COLON CANCER
|
|
ATE545651T1
(en)
|
2002-06-13 |
2012-03-15 |
Novartis Vaccines & Diagnostic |
VECTORS FOR EXPRESSING HML-2 POLYPEPTIDES
|
|
EP1541586A4
(en)
*
|
2002-07-22 |
2006-08-09 |
Astellas Pharma Inc |
Novel gene associated with rheumatoid arthritis
|
|
CA2495177C
(en)
|
2002-08-14 |
2014-01-21 |
National Institute Of Advanced Industrial Science And Technology |
Novel n-acetylgalactosamine transferases and nucleic acids encoding the same
|
|
AU2003243151A1
(en)
|
2002-08-16 |
2004-03-03 |
Agensys, Inc. |
Nucleic acid and corresponding protein entitled 251p5g2 useful in treatment and detection of cancer
|
|
AU2003235316A1
(en)
*
|
2002-08-23 |
2004-03-11 |
Japan Science And Technology Agency |
Human solid cancer antigen peptides, polynucleotides encoding the same and utilization thereof
|
|
EP1540014A2
(en)
*
|
2002-08-27 |
2005-06-15 |
Epigenomics AG |
Method and nucleic acids for the analysis of breast cell proliferative disorders
|
|
US7452969B2
(en)
|
2002-08-30 |
2008-11-18 |
Licentia Ltd |
Neurotrophic factor protein and uses thereof
|
|
DE60325628D1
(en)
|
2002-09-30 |
2009-02-12 |
Oncotherapy Science Inc |
GENES AND POLYPEPTIDES IN CONNECTION WITH HUMAN PANCREATIC CARCINOMAS
|
|
WO2004035823A2
(en)
*
|
2002-10-17 |
2004-04-29 |
Evotec Neurosciences Gmbh |
Diagnostic and therapeutic use of the nicotinamide mononucleotide adenylytransferase 2 (nmnat-2) gene and protein for neurodegenerative diseases
|
|
AU2002952216A0
(en)
*
|
2002-10-23 |
2002-11-07 |
The Walter And Eliza Hall Institute Of Medical Research |
Novel therapeutic molecules
|
|
US7554021B2
(en)
|
2002-11-12 |
2009-06-30 |
Northwestern University |
Composition and method for self-assembly and mineralization of peptide amphiphiles
|
|
US8008003B2
(en)
|
2002-11-15 |
2011-08-30 |
Genomic Health, Inc. |
Gene expression profiling of EGFR positive cancer
|
|
DE10254601A1
(en)
|
2002-11-22 |
2004-06-03 |
Ganymed Pharmaceuticals Ag |
Gene products differentially expressed in tumors and their use
|
|
AU2002953341A0
(en)
*
|
2002-12-13 |
2003-01-09 |
The Walter And Eliza Hall Institute Of Medical Research |
A novel phosphoprotein
|
|
AU2003287764B2
(en)
*
|
2002-12-13 |
2010-01-21 |
The Walter And Eliza Hall Institute Of Medical Research |
A novel phosphoprotein
|
|
US20040231909A1
(en)
|
2003-01-15 |
2004-11-25 |
Tai-Yang Luh |
Motorized vehicle having forward and backward differential structure
|
|
US7326768B2
(en)
|
2003-02-05 |
2008-02-05 |
Juan Saus |
Goodpasture antigen-binding protein isoforms and protein misfolded-mediated disorders
|
|
EP1445614A1
(en)
*
|
2003-02-06 |
2004-08-11 |
Institut National De La Sante Et De La Recherche Medicale (Inserm) |
A method for the in vitro assessment of the progression status of an HIV virus in an invidual
|
|
US7074891B2
(en)
|
2003-02-07 |
2006-07-11 |
Posco |
Leukocyte stimulating peptides
|
|
EP1597391B1
(en)
|
2003-02-20 |
2008-10-29 |
Genomic Health, Inc. |
Use of intronic rna to measure gene expression
|
|
US20060142222A1
(en)
*
|
2003-03-04 |
2006-06-29 |
Makoto Ogino |
Novel gene relating to fibrotic conditions
|
|
UA87106C2
(en)
*
|
2003-03-19 |
2009-06-25 |
Байоджен Айдек Ма Інк. |
Nogo receptor binding protein
|
|
ITRM20030149A1
(en)
|
2003-04-02 |
2004-10-03 |
Giuliani Spa |
ANTISENSE OLIGONUCLEOTIDES (ODN) FOR SMAD7 AND THEIR USE IN THE MEDICAL FIELD
|
|
AU2003901671A0
(en)
*
|
2003-04-02 |
2003-05-01 |
The University Of Adelaide |
Comparative genomic hybridization
|
|
WO2005039382A2
(en)
|
2003-06-24 |
2005-05-06 |
Genomic Health |
Prediction of likelihood of cancer recurrence
|
|
ES2905579T3
(en)
|
2003-07-10 |
2022-04-11 |
Genomic Health Inc |
Expression profiling algorithm and test for prognosis of breast cancer relapse
|
|
JP4643450B2
(en)
|
2003-08-08 |
2011-03-02 |
株式会社ペルセウスプロテオミクス |
Cancer high expression gene
|
|
US20050136434A1
(en)
*
|
2003-08-12 |
2005-06-23 |
Mai Xu |
Isolated heat-inducible cell surface protein and hyperthermia-based tumor immunotargeting therapy
|
|
US20070178458A1
(en)
*
|
2003-09-05 |
2007-08-02 |
O'brien Philippa |
Methods of diagnosis and prognosis of ovarian cancer II
|
|
TW200517503A
(en)
*
|
2003-09-10 |
2005-06-01 |
Japan Science & Tech Agency |
Group of genes differentially expressed in peripheral blood cells and diagnostic method and assay method using the same
|
|
ES2346314T3
(en)
*
|
2003-10-02 |
2010-10-14 |
Glaxosmithkline Biolog Sa |
ANTIGENS OF B. PERTUSSIS AND USE OF THE SAME IN VACCINATION.
|
|
EP1685159B1
(en)
|
2003-10-03 |
2012-08-01 |
Brigham & Women's Hospital |
Tim-3 polypeptides
|
|
WO2005040791A2
(en)
*
|
2003-10-21 |
2005-05-06 |
Bayer Healthcare Ag |
Diagnostics and therapeutics for diseases associated with somatostatin- and angiogenin-like peptide receptor (salpr)
|
|
WO2005051994A2
(en)
*
|
2003-11-21 |
2005-06-09 |
Zymogenetics, Inc. |
Ztnf11, a tumor necrosis factor
|
|
EP2314305A3
(en)
|
2003-12-05 |
2011-08-10 |
Northwestern University |
Self-assembling peptide amphiphiles and related methods for growth factor delivery
|
|
ATE498022T1
(en)
|
2003-12-23 |
2011-02-15 |
Genomic Health Inc |
UNIVERSAL DUPLICATION OF FRAGMENTED RNA
|
|
US20050186577A1
(en)
|
2004-02-20 |
2005-08-25 |
Yixin Wang |
Breast cancer prognostics
|
|
PL1730303T3
(en)
*
|
2004-03-02 |
2014-04-30 |
Univ Johns Hopkins |
Mutations of the pik3ca gene in human cancers
|
|
TW200539890A
(en)
|
2004-03-12 |
2005-12-16 |
Brigham & Womens Hospital |
Methods of modulating immune responses by modulating tim-1, tim-2 and tim-4 function
|
|
WO2005090569A1
(en)
*
|
2004-03-24 |
2005-09-29 |
The Council Of The Queensland Institute Of Medical Research |
Cancer and testis vsm1 and vsm2 nucleic acids, proteins and uses thereof
|
|
ATE430763T1
(en)
*
|
2004-03-30 |
2009-05-15 |
Nsgene As |
THERAPEUTIC USE OF GROWTH FACTOR NSG33
|
|
EP2163650B1
(en)
|
2004-04-09 |
2015-08-05 |
Genomic Health, Inc. |
Gene expression markers for predicting response to chemotherapy
|
|
DE102004024617A1
(en)
|
2004-05-18 |
2005-12-29 |
Ganymed Pharmaceuticals Ag |
Differentially expressed in tumors gene products and their use
|
|
WO2005118832A2
(en)
*
|
2004-06-01 |
2005-12-15 |
Bayer Healthcare Ag |
Diagnostics and therapeutics for diseases associated with serum/glucocorticoid regulated kinase-like protein (sgkl)
|
|
RS52593B
(en)
|
2004-06-24 |
2013-04-30 |
Biogen Idec Ma Inc. |
TREATMENT OF THE CONDITIONS CONCERNING DEMYELINIZATION
|
|
US7587279B2
(en)
|
2004-07-06 |
2009-09-08 |
Genomic Health |
Method for quantitative PCR data analysis system (QDAS)
|
|
ES2328261T3
(en)
*
|
2004-08-05 |
2009-11-11 |
Toagosei Co., Ltd. |
EPITHOPIC PEPTIDE OF AN ANTIBODY OF CROHN'S DISEASE AND REAGENT TO TEST CROHN'S DISEASE.
|
|
JP5020088B2
(en)
|
2004-11-05 |
2012-09-05 |
ジェノミック ヘルス， インコーポレイテッド |
Predicting response to chemotherapy using gene expression markers
|
|
AU2005304878B2
(en)
|
2004-11-05 |
2010-07-08 |
Genomic Health, Inc. |
Molecular indicators of breast cancer prognosis and prediction of treatment response
|
|
AU2005304624B2
(en)
|
2004-11-12 |
2010-10-07 |
Xencor, Inc. |
Fc variants with altered binding to FcRn
|
|
US8367805B2
(en)
|
2004-11-12 |
2013-02-05 |
Xencor, Inc. |
Fc variants with altered binding to FcRn
|
|
WO2006096614A2
(en)
|
2005-03-04 |
2006-09-14 |
Northwestern University |
Angiogenic heparin binding peptide amphiphiles
|
|
WO2006120019A2
(en)
*
|
2005-05-13 |
2006-11-16 |
Centre National De La Recherche Scientifique |
Mcm9, a member of the mcm2-8 family and its use in pharmaceutical compositions
|
|
ES2434470T3
(en)
|
2005-07-08 |
2013-12-16 |
Biogen Idec Ma Inc. |
SP35 antibodies and their uses
|
|
WO2007014338A2
(en)
*
|
2005-07-26 |
2007-02-01 |
Siemens Medical Solutions Diagnostics |
Single nucleotide polymorphisms associated with susceptibility to cardiovascular disease
|
|
WO2007037601A1
(en)
*
|
2005-09-28 |
2007-04-05 |
Knu-Industry Cooperation Foundation |
Polypeptide inhibiting transmigration of leukocytes or growth and/or metastasis of cancer cells, and fusion protein thereof
|
|
EP1790664A1
(en)
|
2005-11-24 |
2007-05-30 |
Ganymed Pharmaceuticals AG |
Monoclonal antibodies against claudin-18 for treatment of cancer
|
|
ES2352205T3
(en)
|
2005-12-14 |
2011-02-16 |
Licentia Ltd. |
USES OF A NEUROTROPHIC FACTOR PROTEIN.
|
|
JP2009540852A
(en)
*
|
2006-07-03 |
2009-11-26 |
エグゾニ・テラピューティック・ソシエテ・アノニム |
Prostate-specific transcripts and their use in the treatment and diagnosis of prostate cancer
|
|
WO2008030559A2
(en)
*
|
2006-09-08 |
2008-03-13 |
Corixa Corporation |
Methods, compositions, and kits for the detection and monitoring of colon cancer
|
|
US8076295B2
(en)
|
2007-04-17 |
2011-12-13 |
Nanotope, Inc. |
Peptide amphiphiles having improved solubility and methods of using same
|
|
US8999634B2
(en)
*
|
2007-04-27 |
2015-04-07 |
Quest Diagnostics Investments Incorporated |
Nucleic acid detection combining amplification with fragmentation
|
|
GB0805159D0
(en)
*
|
2008-03-19 |
2008-04-23 |
Sancho Madrid David |
Immune modulation via C-type lectin
|
|
WO2009015842A2
(en)
*
|
2007-07-27 |
2009-02-05 |
Immatics Biotechnologies Gmbh |
Novel immunogenic epitopes for immunotherapy
|
|
US7863021B2
(en)
|
2007-09-05 |
2011-01-04 |
Celera Corporation |
Genetic polymorphisms associated with rheumatoid arthritis, methods of detection and uses thereof
|
|
WO2009034661A1
(en)
*
|
2007-09-12 |
2009-03-19 |
Toppan Printing Co., Ltd. |
Method for diagnosis and induction of resistance to virus
|
|
JP2011500047A
(en)
|
2007-10-17 |
2011-01-06 |
ウニベルシダ・ドゥ・コルドバ |
Human somatostatin receptor type 5 isoforms produced by alternative processing and oligonucleotide pairs for their detection by PCR
|
|
DK2808343T3
(en)
|
2007-12-26 |
2019-08-19 |
Xencor Inc |
Fc variants with altered binding to FcRn
|
|
GB0803352D0
(en)
*
|
2008-02-22 |
2008-04-02 |
Ntnu Technology Transfer As |
Oligopeptidic compounds and uses thereof
|
|
US12492253B1
(en)
|
2008-02-25 |
2025-12-09 |
Xencor, Inc. |
Anti-human C5 antibodies
|
|
US9683031B2
(en)
|
2008-03-21 |
2017-06-20 |
Universiteit Hasselt |
Biomarkers for rheumatoid arthritis
|
|
AU2009269099B2
(en)
|
2008-07-09 |
2016-03-10 |
Biogen Ma Inc. |
Compositions comprising antibodies to LINGO or fragments thereof
|
|
US8334264B2
(en)
|
2008-07-24 |
2012-12-18 |
NsGenee A/S |
Therapeutic use of a growth factor, METRNL
|
|
EP2172211B1
(en)
|
2008-10-01 |
2014-12-03 |
Immatics Biotechnologies GmbH |
Composition of tumor-associated peptides and related anti-cancer vaccine for the treatment of glioblastoma (GBM) and other cancers
|
|
JP2012508586A
(en)
|
2008-11-14 |
2012-04-12 |
ジェン−プローブ・インコーポレーテッド |
Compositions, kits and methods for detecting Campylobacter nucleic acids
|
|
US20110229471A1
(en)
|
2008-11-26 |
2011-09-22 |
Cedars-Sinai Medical Center |
Methods of determining responsiveness to anti-tnf alpha therapy in inflammatory bowel disease
|
|
CA2745849A1
(en)
*
|
2008-12-09 |
2010-06-17 |
Alethia Biotherapeutics Inc. |
Novel human endogenous retorviral erv3 variant and uses thereof for diagnosing ovarian cancer
|
|
KR20120012811A
(en)
|
2009-04-13 |
2012-02-10 |
노오쓰웨스턴 유니버시티 |
Novel peptide-based scaffolds for cartilage regeneration and methods of using them
|
|
US9493578B2
(en)
|
2009-09-02 |
2016-11-15 |
Xencor, Inc. |
Compositions and methods for simultaneous bivalent and monovalent co-engagement of antigens
|
|
EP2528615B1
(en)
|
2010-01-27 |
2020-05-13 |
Massachusetts Institute of Technology |
Engineered polypeptide agents for targeted broad spectrum influenza neutralization
|
|
ES2874306T3
(en)
|
2010-09-29 |
2021-11-04 |
Agensys Inc |
Conjugates of antibodies and drugs (CAF) that bind to 191P4D12 proteins
|
|
JP6149226B2
(en)
|
2010-10-01 |
2017-06-21 |
ホーバ セラピューティクス アンパルトセルスカブ |
Treatment of allodynia, hyperalgesia, spontaneous pain and phantom limb pain
|
|
DK2651430T3
(en)
|
2010-12-14 |
2018-08-27 |
Hananja Ehf |
Biological activity of placental protein 13
|
|
CA2846511C
(en)
|
2011-09-05 |
2021-07-13 |
Nsgene A/S |
Treatment of allodynia, hyperalgsia, spontaneous pain, and phantom pain with cometin
|
|
WO2013068445A1
(en)
*
|
2011-11-09 |
2013-05-16 |
Sanofi |
Diacylglycerol lipase and uses thereof
|
|
CN108503711A
(en)
|
2012-04-30 |
2018-09-07 |
比奥孔有限公司 |
Targeting/immune regulative fusion protein and its manufacturing method
|
|
WO2013167153A1
(en)
|
2012-05-09 |
2013-11-14 |
Ganymed Pharmaceuticals Ag |
Antibodies useful in cancer diagnosis
|
|
AU2013262934B2
(en)
|
2012-05-14 |
2018-02-01 |
Biogen Ma Inc. |
LINGO-2 antagonists for treatment of conditions involving motor neurons
|
|
WO2013174404A1
(en)
|
2012-05-23 |
2013-11-28 |
Ganymed Pharmaceuticals Ag |
Combination therapy involving antibodies against claudin 18.2 for treatment of cancer
|
|
RU2678127C2
(en)
|
2012-11-13 |
2019-01-23 |
Бионтех Аг |
Agents for treatment of claudin expressing cancer diseases
|
|
WO2014127785A1
(en)
|
2013-02-20 |
2014-08-28 |
Ganymed Pharmaceuticals Ag |
Combination therapy involving antibodies against claudin 18.2 for treatment of cancer
|
|
CA2902830C
(en)
|
2013-03-12 |
2023-09-19 |
Biocon Ltd. |
Fusion immunomodulatory proteins and methods for making same
|
|
US9023353B2
(en)
*
|
2013-03-13 |
2015-05-05 |
The Board Of Trustees Of The University Of Arkansas |
Anti-(+)—methamphetamine monoclonal antibodies
|
|
WO2014146672A1
(en)
|
2013-03-18 |
2014-09-25 |
Ganymed Pharmaceuticals Ag |
Therapy involving antibodies against claudin 18.2 for treatment of cancer
|
|
EP2978440B1
(en)
|
2013-03-27 |
2019-10-02 |
Cedars-Sinai Medical Center |
Treating fibrosis by inhibiting tl1a and diagnosing fibrosis by detecting il31ra
|
|
RS62529B1
(en)
|
2013-07-11 |
2021-11-30 |
Modernatx Inc |
Compositions comprising synthetic polynucleotides encoding crispr related proteins and synthetic sgrnas and methods of use
|
|
EP3022295A4
(en)
|
2013-07-19 |
2017-03-01 |
Cedars-Sinai Medical Center |
Signature of tl1a (tnfsf15) signaling pathway
|
|
RU2715232C2
(en)
|
2013-09-25 |
2020-02-26 |
Сайтомкс Терапьютикс, Инк. |
Substrates of matrix metalloproteinase and other cleavable moieties and methods for use thereof
|
|
US20160367651A1
(en)
*
|
2013-10-01 |
2016-12-22 |
Mie University |
T cell inducing vaccine containing an interepitope sequence that promotes antigen presentation
|
|
ES2932777T3
(en)
|
2014-01-31 |
2023-01-25 |
Cytomx Therapeutics Inc |
Substrates of matriptase and plasminogen activator-u and other cleavable motifs and methods of using the same
|
|
CA2973266A1
(en)
|
2015-01-08 |
2016-07-14 |
Biogen Ma Inc. |
Lingo-1 antagonists and uses for treatment of demyelinating disorders
|
|
MA41374A
(en)
|
2015-01-20 |
2017-11-28 |
Cytomx Therapeutics Inc |
MATRIX METALLOPROTEASE CLIVABLE AND SERINE PROTEASE CLIVABLE SUBSTRATES AND METHODS OF USE THEREOF
|
|
US11124766B2
(en)
|
2015-06-12 |
2021-09-21 |
Emory University |
Growth and survival compositions for cells capable of producing antibodies and methods related thereto
|
|
EP3344776B1
(en)
*
|
2015-09-04 |
2021-06-16 |
Synthetic Genomics, Inc. |
Rekombinant algal microorganism with increased productivity
|
|
CN118773299A
(en)
|
2016-03-17 |
2024-10-15 |
西达-赛奈医疗中心 |
Method for diagnosing inflammatory bowel disease through RNASET2
|
|
US20200330606A1
(en)
*
|
2016-03-29 |
2020-10-22 |
Valkyrie Therapeutics Inc. |
Modulation of structural maintenance of chromosome-1 expression
|
|
US9611297B1
(en)
|
2016-08-26 |
2017-04-04 |
Thrasos Therapeutics Inc. |
Compositions and methods for the treatment of cast nephropathy and related conditions
|
|
US11125757B2
(en)
|
2017-05-26 |
2021-09-21 |
Emory University |
Methods of culturing and characterizing antibody secreting cells
|
|
EP3508499A1
(en)
|
2018-01-08 |
2019-07-10 |
iOmx Therapeutics AG |
Antibodies targeting, and other modulators of, an immunoglobulin gene associated with resistance against anti-tumour immune responses, and uses thereof
|
|
AU2019392090A1
(en)
|
2018-12-03 |
2021-06-17 |
Agensys, Inc. |
Pharmaceutical compositions comprising anti-191P4D12 antibody drug conjugates and methods of use thereof
|
|
KR20210102318A
(en)
|
2018-12-06 |
2021-08-19 |
싸이톰스 테라퓨틱스, 인크. |
Matrix metalloprotease-cleavable substrates and serine or cysteine protease-cleavable substrates and methods of use thereof
|
|
TW202106700A
(en)
*
|
2019-04-26 |
2021-02-16 |
美商聖加莫治療股份有限公司 |
Engineering aav
|
|
KR20220051164A
(en)
|
2019-07-05 |
2022-04-26 |
아이오엠엑스 테라퓨틱스 아게 |
Antibody binding IGC2 of IGSF11 (VSIG3) and uses thereof
|
|
US20220288235A1
(en)
*
|
2019-08-20 |
2022-09-15 |
St. Jude Children's Research Hospital, Inc. |
SCHIZOPHRENIA-RELATED MICRODELETION GENE 2510002D24Rik IS ESSENTIAL FOR SOCIAL MEMORY
|
|
US12280096B2
(en)
|
2021-07-12 |
2025-04-22 |
Penland Foundation |
Treatments of cancer using nitrous oxide and botulinum toxin
|
|
WO2021083958A1
(en)
*
|
2019-10-29 |
2021-05-06 |
Specialites Pet Food |
Novel peptides inducing satiety
|
|
BR112022019454A2
(en)
*
|
2020-03-27 |
2022-12-13 |
Onecuregen Co Ltd |
COMPOSITION COMPRISING VGLL1 PEPTIDE FOR CANCER TREATMENT
|
|
WO2021228999A1
(en)
*
|
2020-05-12 |
2021-11-18 |
Institut Curie |
Neoantigenic epitopes associated with sf3b1 mutations
|
|
CA3178965A1
(en)
|
2020-05-15 |
2021-11-18 |
Christian COBAUGH |
Messenger rna encoding cas9 for use in genome-editing systems
|
|
EP4175668A1
(en)
|
2020-07-06 |
2023-05-10 |
iOmx Therapeutics AG |
Antibodies binding igv of igsf11 (vsig3) and uses thereof
|
|
WO2022158977A1
(en)
*
|
2021-01-21 |
2022-07-28 |
Erasmus University Medical Center Rotterdam |
T cells for use in therapy
|
|
US20220260597A1
(en)
*
|
2021-02-18 |
2022-08-18 |
Beren Therapeutics P.B.C. |
Methods for the treatment of familial heterozygous and homozygous hypercholesterolemia with cyclodextrins
|
|
CA3209014A1
(en)
*
|
2021-02-19 |
2022-08-25 |
Nuclear Rna Networks, Inc. |
Compositions and methods for modulating gene transcription networks based on shared high identity transposable element remnant sequences and nonprocessive promoter and promoter-proximal transcript
|
|
WO2023225602A1
(en)
*
|
2022-05-20 |
2023-11-23 |
Medikine, Inc. |
Interleukin-18 receptor binding polypeptides and uses thereof
|